CTLs heterogeneity and plasticity: implications for cancer immunotherapy.

Area of Science:

• Immunology
• Cancer Biology
• Cellular and Molecular Medicine

Background:

• Cytotoxic T lymphocytes (CTLs) are crucial for antitumor immunity, involving diverse subsets beyond CD8+ T cells.
• Current biomarkers for CTLs are insufficient, as cytotoxicity molecule expression doesn't guarantee functional capacity.
• While transcriptional regulation is known, the epigenetic control of CTLs remains poorly understood.

Purpose of the Study:

• To review the current understanding of CTL subsets, biomarkers, differentiation, and cancer-related functions.
• To explore strategies for enhancing CTL cytotoxicity in antitumor immunity.
• To identify key knowledge gaps and future research directions in CTL biology.

Main Methods:

• Literature review synthesizing existing research on CTLs.
• Analysis of CTL heterogeneity, regulatory mechanisms, and functional roles.
• Identification of challenges and opportunities in CTL-based cancer immunotherapy.

Main Results:

• CTLs encompass diverse subsets (CD4+, NK, γδ T cells) with varied antitumor functions.
• Definitive CTL biomarkers and epigenetic regulation mechanisms are still elusive.
• CTLs can promote tumor killing but also contribute to tumorigenesis in certain contexts.

Conclusions:

• A comprehensive understanding of CTL heterogeneity, regulation, and function is essential for optimizing cancer immunotherapy.
• Further research is needed to refine CTL definitions, identify biomarkers, elucidate epigenetic control, and explore microbial interactions.
• Addressing these knowledge gaps will improve the strategic application of CTLs in cancer treatment.